Cyberonics Inc. To Present At The 33rd Annual J.P. Morgan Healthcare Conference
HOUSTON, Dec. 22, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015, in San Francisco.
Dan Moore, Cyberonics' President and Chief Executive Officer, will speak at 11:00 AM Pacific Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at www.cyberonics.com on January 14, 2015.
About Cyberonics, Inc. and the VNS Therapy® System
Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.
Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.
Contact Information
Greg Browne, CFO
Cyberonics, Inc.
100 Cyberonics Blvd.
Houston, TX 77058
Main: (281) 228-7262
Fax: (281) 218-9332
ir@cyberonics.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cyberonics-to-present-at-the-33rd-annual-jp-morgan-healthcare-conference-300012271.html
SOURCE Cyberonics, Inc.